Nasal spray could shrink polyps and reduce need for surgery
NCT ID NCT07675512
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests whether a nasal spray containing adelmidrol can reduce inflammation and shrink nasal polyps in people with chronic sinusitis. Participants are adults aged 18 to 70 who are scheduled for sinus surgery. Half receive standard care plus the adelmidrol spray, while the other half receive standard care alone. The study measures polyp size, symptoms, and whether the spray improves recovery after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- adelmidrol nasal spray
- What this could lead to
- If it works, this could offer a new way to control nasal polyps and reduce the need for surgery in some patients.
- What could go wrong
- This is a small, early-stage study. The results may not apply to everyone, and the spray may not work better than standard treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SINUSITIS WITH NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ospedale di Fano, Dipartimento di Otorinolaringoiatria
Fano, Italy